CH628051A5 - Process for the preparation of N-alkylated derivatives of thienamycin - Google Patents

Process for the preparation of N-alkylated derivatives of thienamycin Download PDF

Info

Publication number
CH628051A5
CH628051A5 CH1462176A CH1462176A CH628051A5 CH 628051 A5 CH628051 A5 CH 628051A5 CH 1462176 A CH1462176 A CH 1462176A CH 1462176 A CH1462176 A CH 1462176A CH 628051 A5 CH628051 A5 CH 628051A5
Authority
CH
Switzerland
Prior art keywords
carbon atoms
radical
alkyl
group
thienamycin
Prior art date
Application number
CH1462176A
Other languages
German (de)
English (en)
Inventor
Burton Grant Christensen
Raymond Armond Firestone
William Joseph Leanza
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of CH628051A5 publication Critical patent/CH628051A5/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D477/00—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
    • C07D477/10—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D477/12—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6
    • C07D477/16—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6 with hetero atoms or carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 3
    • C07D477/20—Sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/14—Drugs for genital or sexual disorders; Contraceptives for lactation disorders, e.g. galactorrhoea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/06—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D205/08—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
CH1462176A 1975-11-21 1976-11-19 Process for the preparation of N-alkylated derivatives of thienamycin CH628051A5 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US63429775A 1975-11-21 1975-11-21

Publications (1)

Publication Number Publication Date
CH628051A5 true CH628051A5 (en) 1982-02-15

Family

ID=24543224

Family Applications (1)

Application Number Title Priority Date Filing Date
CH1462176A CH628051A5 (en) 1975-11-21 1976-11-19 Process for the preparation of N-alkylated derivatives of thienamycin

Country Status (8)

Country Link
JP (1) JPS5277085A (fr)
CH (1) CH628051A5 (fr)
DE (1) DE2652676A1 (fr)
DK (1) DK523676A (fr)
FR (1) FR2332014A1 (fr)
GB (1) GB1570988A (fr)
NL (1) NL7612937A (fr)
SE (1) SE7612964L (fr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU531084B2 (en) * 1977-10-19 1983-08-11 Merck & Co., Inc. Azetidine derivatives
AU4061378A (en) * 1977-10-19 1980-04-17 Merck & Co., Inc. 1-azabicyclo (3.2.0) hept-2-enes
DE2966187D1 (en) * 1978-08-23 1983-10-27 Beecham Group Plc Beta-lactam antibacterial compounds, their preparation and pharmaceutical compositions containing them
EP0082133A3 (en) * 1979-04-19 1983-07-20 Merck & Co. Inc. A process for preparing intermediates useful for preparing 2-substituted-6-substituted-1-carbadethiapen-2-em-3-carboxylic acids
US4376774A (en) * 1979-05-29 1983-03-15 Merck & Co., Inc. Antibiotic N-heterocyclyl thienamycin
DE3167774D1 (en) * 1980-02-28 1985-01-31 Fujisawa Pharmaceutical Co 4-substituted-2-oxoazetidine compounds, processes for their preparation, and their use for preparing antibiotics
JPS5798257A (en) * 1980-12-10 1982-06-18 Sankyo Co Ltd 3,4-disubstituted azetidine-2-one compound and its preparation
EP0062407A1 (fr) * 1981-03-10 1982-10-13 Beecham Group Plc Composés thérapeutiques à cycle bête-lactame
US4552696A (en) * 1982-04-09 1985-11-12 Bristol-Myers Company Carbapenem antibiotics
US4536335A (en) * 1982-06-18 1985-08-20 Bristol-Myers Company Carbapenem antibiotics
JPS5910588A (ja) * 1982-06-18 1984-01-20 ブリストル―マイヤーズ　スクイブ　カンパニー カルバペネム抗生物質
MXPA06001115A (es) * 2003-12-09 2006-04-11 Choongwae Pharm Co Un proceso nuevo para la preparacion de imipenem.

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3950357A (en) * 1974-11-25 1976-04-13 Merck & Co., Inc. Antibiotics

Also Published As

Publication number Publication date
DE2652676A1 (de) 1977-06-02
JPS5277085A (en) 1977-06-29
SE7612964L (sv) 1977-05-22
GB1570988A (en) 1980-07-09
NL7612937A (nl) 1977-05-24
FR2332014B1 (fr) 1978-11-10
FR2332014A1 (fr) 1977-06-17
DK523676A (da) 1977-05-22

Similar Documents

Publication Publication Date Title
DE3587126T2 (de) Carbapenem-Derivate und sie enthaltende Zusammensetzung.
DE2751624A1 (de) 1-carba-2-penem-3-carbonsaeure
DE2819479A1 (de) N-alkyl-n-acylderivate von thienamycin
US4217453A (en) 6-Amido-3-substituted-amino-1-azabicyclo[3.2.0]hept-2-en-7-one-2-carboxylic acid
US4235920A (en) N-Alkylated derivatives of thienamycin
CH628051A5 (en) Process for the preparation of N-alkylated derivatives of thienamycin
US4150145A (en) N-alkylated derivatives of thienamycin sulfoxide and sulfone
US4226870A (en) O-, N- and carboxyl derivatives of thienamycin
US4172144A (en) Schiff's base derivatives of thienamycin
DE2652674A1 (de) N- und carboxylderivate von thienamycin
DE2652679C2 (fr)
DE3317742C2 (fr)
BE848545A (fr) Derives n-methylene substitues de thienamycine,
US4196211A (en) 6-(α-Hydroxyethyl)-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid and derivatives thereof
DE2652680A1 (de) O-, n- und carboxylderivate von thienamycin, verfahren zu deren herstellung und diese enthaltende arzneimittel
DE2652675C2 (fr)
US4374849A (en) 6-Amidocyclonocardicins
EP0278911A1 (fr) Acides bêta-lactame carboxyliques bicycliques
DE2724560A1 (de) O-derivate von thienamycin
DE69909098T2 (de) C-2 s/o- und s/n-formaldehydacetal-derivate von carbapenem-3-carbonsäuren und deren verwendung als antibiotika und beta-lactamas-inhibitoren
DE2448582A1 (de) Verfahren zur herstellung von cephalosporinen
US4208330A (en) O-Derivatives of thienamycin
KR800001674B1 (ko) 티에나마이신의 치환된 n-메틸렌 유도체 제법
DE3630857A1 (de) Carbapenem-antibiotika, verfahren zu deren herstellung und diese verbindungen enthaltende pharmazeutische mittel
AT387574B (de) Verfahren zur herstellung neuer carbapenem-derivate

Legal Events

Date Code Title Description
PL Patent ceased